Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent.
about
RETRACTED: Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus researchThe neuroinvasiveness of a murine retrovirus is influenced by a dileucine-containing sequence in the cytoplasmic tail of glycosylated Gag.N-terminal cleavage fragment of glycosylated Gag is incorporated into murine oncornavirus particles.MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.Profile of Stephen P. Goff. Interview by Greg WilliamsAntiretroviral restriction factors in mice.RNA sequences in the Moloney murine leukemia virus genome bound by the Gag precursor protein in the yeast three-hybrid system.Murine leukemia viruses: objects and organisms.The dimerization/packaging sequence is dispensable for both the formation of high-molecular-weight RNA complexes within retroviral particles and the synthesis of proviruses of normal structure.cis-active structural motifs involved in specific encapsidation of Moloney murine leukemia virus RNA.Characterization of glycosylated Gag expressed by a neurovirulent murine leukemia virus: identification of differences in processing in vitro and in vivo.Construction of mutants of Moloney murine leukemia virus by suppressor-linker insertional mutagenesis: positions of viable insertion mutations.A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia virusesIdentification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus.Novel GACG-hairpin pair motif in the 5' untranslated region of type C retroviruses related to murine leukemia virus.Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: effects on RNA packaging and reverse transcription.Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen.Assembly of gag-beta-galactosidase proteins into retrovirus particles.Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA.Monoclonal antibody to the amino-terminal L sequence of murine leukemia virus glycosylated gag polyproteins demonstrates their unusual orientation in the cell membrane.Effects of 5-azacytidine on expression of endogenous retrovirus-related sequences in C3H 10T1/2 cellsThe neurovirulent determinants of ts1, a paralytogenic mutant of Moloney murine leukemia virus TB, are localized in at least two functionally distinct regions of the genome.Analysis of retroviral pol gene products with antisera raised against fusion proteins produced in Escherichia coliEvidence that the packaging signal of Moloney murine leukemia virus extends into the gag region.Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex.Reverse transcription of retroviral genomes: mutations in the terminal repeat sequences.Recombination between a defective retrovirus and homologous sequences in host DNA: reversion by patch repair.A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.A 1.6-kilobase-pair fragment in the genome of the ts1 mutant of Moloney murine leukemia virus TB that is associated with temperature sensitivity, nonprocessing of Pr80env, and paralytogenesis.Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAsMutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infectionMutations in the gag gene of Moloney murine leukemia virus: effects on production of virions and reverse transcriptaseA membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitroExpression of the precore region of an avian hepatitis B virus is not required for viral replication.Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein.Expression of enzymatically active reverse transcriptase in Escherichia coli.Bipartite signal for genomic RNA dimerization in Moloney murine leukemia virus.cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA.A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging.
P2860
Q21090538-371EF5B1-5DBD-4F21-B21E-0A3AD17F2914Q24651042-1EF6FE7C-F5D0-4E12-8E2F-AA0078309736Q33785057-F30C007B-FBA4-4CB4-91AC-09D3BACB1F24Q33849448-8627D19A-1C07-4014-84A5-C06C93743ED7Q33927183-8873C446-0EAD-4E1A-93C5-A1AC86295585Q34154460-9E1CF671-59C6-45EC-9B84-54FD1A297376Q34623866-DA4C3302-A514-46F1-9184-C030401DC1A0Q35122730-0719C56B-D4A4-47CC-B90E-2B06E1B11AF5Q35692330-DD6ACCAF-0612-43E4-B87A-D24494D99BEDQ35832442-003C5C32-FB88-4458-B961-967B45C5A051Q35865815-7612833A-4DC0-4AB3-8181-01EF20B42807Q35888352-97599BE9-9E04-4BC0-84E2-DD0FFAB1E5DBQ36264899-74CBF08F-B63B-4BC7-B01B-BAD135F9AEC2Q36634291-92C548A5-F037-43C2-8A61-CF0D8602ED24Q36634317-AFF35895-C3A7-49E4-B168-D335AA0A73D6Q36690303-8D50930E-B155-435C-B198-1DA6393F8EDEQ36780266-456006A4-497C-44EF-9BC1-86E8C12ED746Q36802480-DBC44C63-4B0F-4AF2-A856-41007B09C8E0Q36805988-B12000A1-8040-4329-88BD-67C3D1ECA555Q36855313-C47476CC-48C7-47FC-89DA-6F8E18E26416Q36857182-5BC07C28-6F87-44D7-A12E-A4BD848B0608Q36860092-8B16593E-3844-46D8-881C-CD754F4C392DQ36864174-399C02EA-A029-45CF-A4AD-F289BFBB35F2Q36864640-26015295-ED3C-460A-9A53-B32838FAC367Q36887904-52796291-9ED7-4AA4-963B-AF2F10E73B49Q36895829-88E7D16C-7C2C-4459-9155-64F132EDD7E0Q36897673-033881F7-9E35-40E5-9769-D4CC625B6C6DQ36898930-CF6BD793-7404-4FDE-A0B3-E53C91250E17Q36899532-27173275-97C8-476C-A8E3-8650F3FC7384Q36901062-9D7E7812-0BBC-4E5D-8CC1-C85F162F9C59Q36901149-CF3C1B29-04E6-4CA3-A63D-BFF6AE7329FBQ36913348-5BB8B24C-F3D5-4684-8165-C47A8D5921D5Q36913383-CF9E6927-C53E-40D6-85E4-C51AD333E5A5Q36918746-EE87307D-AB41-46BE-AE27-FE8213485C85Q36919460-DFA2056B-CAA9-4DFF-9033-C1C386E40F50Q37515362-806EB67A-3928-422A-94F8-F59240B923FDQ37524718-49327C4C-4856-40D6-B959-22B9E8A49D94Q39683048-234CA623-A7C7-4967-8B37-2E518F7787E6Q40107854-71A96542-9969-424A-B251-74D51F81328EQ40127033-1667AD40-238E-49F4-BE1B-4B000D33AD6B
P2860
Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Deletion mutants of Moloney mu ...... ein are replication competent.
@en
type
label
Deletion mutants of Moloney mu ...... ein are replication competent.
@en
prefLabel
Deletion mutants of Moloney mu ...... ein are replication competent.
@en
P2093
P2860
P1433
P1476
Deletion mutants of Moloney mu ...... ein are replication competent.
@en
P2093
J Colicelli
P Schwartzberg
P2860
P304
P407
P577
1983-05-01T00:00:00Z